Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 75 | 66 | 46 | 11 | 0 |
| Gross Profit | 75 | 66 | 46 | 11 | N/A |
| Operating Expenses | 14,247 | 14,959 | 12,219 | 12,815 | 14,304 |
| Operating Income | -14,172 | -14,892 | -12,173 | -12,804 | -14,304 |
| Other Income | 1,764 | 1,536 | 618 | 836 | -284 |
| Pre-tax Income | -12,408 | -13,356 | -11,555 | -11,968 | -14,588 |
| Net Income Continuous | -12,408 | -13,356 | -11,505 | -11,968 | -14,588 |
| Net Income | $-12,408 | $-13,356 | $-11,505 | $-11,968 | $-14,588 |
| EPS Basic Total Ops | -0.18 | -0.19 | -0.16 | -0.17 | -0.21 |
| EPS Basic Continuous Ops | -0.18 | -0.19 | -0.16 | -0.17 | -0.21 |
| EPS Diluted Total Ops | -0.18 | -0.19 | -0.16 | -0.17 | -0.21 |
| EPS Diluted Continuous Ops | -0.18 | -0.19 | -0.16 | -0.17 | -0.21 |
| EBITDA(a) | $-14,035 | $-14,748 | $-11,733 | $-12,389 | $-13,852 |